Knowledge Distillery

There are concerns on the safety of SARS-CoV-2 vaccination in patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory…

60 hospitalized patients with COVID-19 and acute neurological symptoms, 25 (42%) of them with encephalopathy and 14 (23%) with encephalitis, were…

Little is known about trajectories of recovery 12-months after hospitalisation for severe COVID. In this article the authors conducted a prospective,…

Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease…

Cognitive decline is a recognized manifestation of long COVID, even among patients who experienced mild disease. However, there is no evidence…

The objective of this study was to understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis…

In patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (COVID-DoC) have emerged as a serious complication. The…

In this paper recently published in Neurology, the authors aimed to determine whether neurological manifestations are common in hospitalised COVID-19…

In this study, recently published in Neurology Neuroimmunology & Neuroinflammation, the authors conducted a survey on the risk of COVID-19 in patients…

In this prospective observational cohort study with rapid data gathering and near real-time analysis, the authors characterised the clinical features…

In this paper just published in the New England Journal of Medicine, the authors report the natural history of asymptomatic SARS-CoV-2 infection from…

In this paper, the authors conducted a prospective national-level data collection of patients treated with mechanical thrombectomy (MT), across 45…